MENU
AKBLF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Alk Abello AS (AKBLF) Ownership - Who owns Alk Abello AS?

Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies... Show more

Profile

Industry
N/A
Address
Boge Alle 6-8
Phone
+45 45747576
Employees
2824
Web
https://www.alk.net

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.46B
P/E Ratio
31.43
Total Cash
517M
Projected Growth
N/A
Total Debt
800M
Revenue
5.71B
Risk (Beta)
0.41
Dividend Yield
N/A
Total Cash/Share
2.34
Total Debt/Equity
N/A
Revenue/Share
3.86 USD as % of share price

Fundamentals

AKBLF
Capitalization
5.46B
P/E Ratio
31.43
Risk (Beta)
0.41
Dividend Yield
N/A
Total Cash
517M
Total Cash/Share
2.34
Total Debt
800M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.86%
Revenue
5.71B
ROE
N/A
Book Value
5.68B
P/B Ratio
5.12
Cash Flow
N/A
Earnings
4.18
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
111M
Current Ratio
2.06
Current Revenue Per Employee
556286.56
Dividends Per Share - Security
0.00
EBITDA
1.55B
Float
N/A
Float - Current
N/A
Gross Income Margin
66.75
Revenue To Assets
12.52
Shares Held By Institutions
2.73B
Shares Outstanding - Current
221M
Total Liabilities
2.51B
Total Volume MTD
N/A
Value
-1
Gain YTD
-10.962
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Boge Alle 6-8
Phone
+45 45747576
Employees
2824
Web
https://www.alk.net